Full Event Guide
An Inside Look at the 2025 Event Program
Early and late-stage analytical development tracks delivering phase-specific strategies and practical insights from top cell therapy developers like Genentech, Bayer, and Novartis
Hands-on pre-conference workshops, including CMLE-accredited flow cytometry training and predictive modeling for potency assay decision-making
Unite with the full spectrum of industry leaders and academic experts sharing real-world case studies on assay validation, tech transfer, and regulatory alignment
Deep dives into breakthrough analytical methods for product characterization, sterility testing, and clinical correlation
Dedicated networking opportunities designed to connect you with peers, regulators, and solution providers, all driving innovation in cell therapy analytics
Cell therapies continue to evolve rapidly, and the clear need for robust analytics to understand and characterize cell therapy drug products continues to grow. A meeting like this is crucial to exchange and share the ideas and information needed to accelerate bringing these therapies to patients
Head, Analytical Development & Testing, Genentech, 2025 Speaker
Having trouble downloading the brochure? Let us know and we'll email it to you instead.
Just Booked:
A Quick Preview of Our Speaking Companies:
